What is Biotium?
Biotium is dedicated to advancing scientific discovery through its comprehensive portfolio of high-quality fluorescent dyes, antibodies, and kits. Their product suite supports critical research areas including microbiology, neuroscience, and cancer research, serving a global clientele of academic institutions and laboratories. With over two decades of experience, Biotium has established itself as a reliable partner for researchers seeking cutting-edge tools and expert technical support to accelerate their scientific explorations.
How much funding has Biotium raised?
Biotium has raised a total of $919K across 2 funding rounds:
Debt
$350K
Debt
$569K
Debt (2020): $350K with participation from PPP
Debt (2021): $569K led by PPP
What's next for Biotium?
The recent major strategic investment positions Biotium for accelerated expansion and further innovation in the life sciences sector. This capital infusion is expected to fuel the development of new research tools and enhance the company's market reach. As Biotium continues to build on its legacy of providing essential reagents, this funding will likely support scaling operations, expanding its product pipeline, and reinforcing its commitment to empowering researchers worldwide with state-of-the-art scientific solutions.
See full Biotium company page
